Recently published biotechnology category reports

January 29, 2013

We have some new market research reports in the biotechnology category which may be beneficial for you.

Take a look at our recently published biotechnology category reports. These are: –

Biologic Therapeutic Drugs: Technologies and Global Markets (BIO079B)

In the 1970s, developments under way that began during World War II ushered in the biotechnology revolution. A pattern of increasing interdependence between pharma and biotech evolved.  Both areas of the industry sought shared risk and lower costs for research.  The result of this collaborative industry has been the development of the biopharmaceutical industry, or biopharma.

The biopharmaceutical sector that emerged is one with extraordinary research demands and, at the same time, phenomenal research promise. This research study provides biologics market overview including information on competitive analysis, geographic distribution of biologics market, merger and acquisitions in biologics area and patents for biologic drugs.

Biologic Imaging Reagents: Technologies and Global Markets (BIO064B)

Biologic imaging reagents comprise an extremely diverse range of technologies and applications.  Imaging reagents are core, enabling technologies in molecular biology, biotechnology, pharmaceuticals and medicine.  Reagents help to detect key molecular and biological processes, and they function as biomarkers in the detection and diagnosis of diseases.

This research report covers the technologies and markets for the following biologic imaging reagents:  fluorescent dyes and probes, fluorescent proteins, nanoparticles (including quantum dots), supermolecules, imaging radiopharmaceuticals and contrast reagents for X-ray/CT, MRI and ultrasound.

Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences (BIO114A)

This report will provide an overview of the various types of instrumentation currently on the market for nanoparticle analysis and highlight new advances in this area.  At present, the U.S. holds the largest number of patents in the nanoparticle area.  This is largely due to the early commercialization of some nanoparticle products by U.S. companies.  It also reflects a larger contribution to the research and development of new ideas by American companies than by those in most other countries.

Global Markets and Technologies for Cell and Tissue Analysis (BIO068B)

The increasing field of cancer research and development is allowing for a focus on cell and tissue analysis products, which play important roles in such areas as the diagnosis of various forms of cancer and other diseases.  These products also assume pivotal roles when it comes to understanding diverse cellular activities.

The cell and tissue analysis (CTA) market is seeing an increasing number of novel analysis products being utilized in the current industry.  This industry is seeing an increase in the development of next-generation cell-analysis tools that target cancers and other diseases, including autoimmune diseases. This report reviews the global market for CTA and provides a detailed analysis.

Single-Use Technologies for Biopharmaceuticals: Global Markets (BIO099A)

Significant changes in biomanufacturing are expected due to the emergence of single-use systems in the commercial stage.  The advantages of single-use technologies such as faster changeovers, reduction in the risk of contamination, improvements over stainless steel systems in cleaning and validation, and a significant reduction in the time and costs involved in setting up a new facility have been key drivers in their adoption in research and development (R&D) and scale-up. This research study will provide an overview of single-use technologies market by technology, end users and applications. It will also highlight prevalent market strategies and competitive environment in the industry.

For a complete listing of report titles for biotechnology, please visit

Apart from the above reports, there are some upcoming reports which you might be interested in. List of such reports is given below: –

  • Top Ten Suppliers of Synthetic Biology Technology (BIO119A)
  • Immunoassays: Technologies and Global Markets (BIO033B)
  • Metabolomics: Technologies and Global Markets (BIO055A)
  • Molecular Diagnostics: Technologies and Global Markets (BIO063B)
  • Proteomics: Technologies and Global Markets (BIO034C)
  • Bioinformatics: Technologies and Global Markets (BIO051B)

For more information on upcoming reports on various categories please click here.


Overall biologics market to grow $239 billion by 2015

September 25, 2012

The overall biologics market was $135 billion in 2009, and is expected to grow to $149 billion in 2010, a 9.4% growth rate. The total market is expected to grow to $239 billion by 2015, a compound annual growth rate (CAGR) of 9.9% since 2010.

Learn about the market for biologics, or biopharmaceuticals, on a global basis. This report includes chapters on industry structure and competitive analysis, markets by product type and disease, biologics manufacturing, pipeline analysis and relevant company profiles…

Use this report to:

  • Understand the factors that will advance biologics, or large molecule drug.
  • Anticipate and prepare for programs that are expected to dominate the biopharmaceutical marketplace and change market dynamics in the coming years.
  • Develop strategies to access emerging markets, specific disease segments, and geographies in order to allocate resources and make effective decisions.
  • Learn about the strategies of companies poised to introduce novel products during the forecast period, how these introductions will change the competitive environment, and how new products and technologies are influencing the current standard of care.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology


Source: BCC Research